首页> 外文期刊>Veterinary Research Communications >Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants
【24h】

Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants

机译:体外硒纳米钠的设计与评价,提高反刍动物硒的吸收

获取原文
获取原文并翻译 | 示例
       

摘要

Sodium selenite is used to prevent selenium deficiency known as nutritional muscular dystrophy or white muscle disease. In ruminants, selenium supplements are transformed partiality in insoluble form by ruminal microorganisms and its process decrease the selenium absorption in digestive gastrointestinal. However, the objective in this research was focused in encapsulated sodium selenite to be release into of a pH less than four, similarity to an intestinal environment. It was encapsulated by nanoprecipitation and emulsion-evaporation methods, within polymeric nanoparticles. The effect of these methods, polymer proportion (Eudragit RL and RS) and solvent (ethanol and acetone) on the physicochemical (drug entrapment, polidispersity index (PDI) and z potential) and morphological characteristics (particle morphology and particle size) were evaluated. Particle size from each nanoparticles, formulation ranged from 36.64 to 213.86 nm. Particle size, z potential and PDI increased (PT0.01) when nanoprecipitation and ethanol were used. No significant differences (P>0.05) were observed when different polymeric proportions were used. Selenium entrapment was 26% when emulsion-evaporation method was used and 78% with nanoprecipitation. Nanoparticles produced by nanoprecipitation were spherical and had a great variation in particle size; on the other hand, nanoparticles produced by emulsion-evaporation were spherical as well as amorphous and presented a homogeneous nanopartcicle size distribution. The release of selenium from nanoparticles was higher in acid pH (less than 4), this condition may represent a better availability of the mineral in the small intestine.
机译:亚硒酸钠用于预防硒缺乏称为营养肌营养不良或白色肌肉疾病。在反刍动物中,通过瘤胃微生物,硒补充剂以不溶性形式转化的偏重率,其过程降低了消化胃肠中的硒吸收。然而,本研究的目的聚焦在包封的硒沸石中被释放成少于四个,与肠环境相似。通过纳米沉淀和乳液蒸发方法在聚合物纳米颗粒内包封。评估这些方法,聚合物比例(Eudragit R1和RS)和溶剂(乙醇和丙酮)对物理化学(药物夹带,药物分子指数(PDI)和Z电位)和形态特征(颗粒形态和粒度)的影响。来自每种纳米颗粒的粒度,配方为36.64至213.86nm。使用纳米尺寸和乙醇时,粒度,Z电位和PDI增加(PT0.01)。当使用不同的聚合物比例时,观察到不同的聚合物比例没有显着差异(p> 0.05)。使用乳液蒸发方法时,硒夹带为26%,纳米尺寸为78%。纳米沉淀制备的纳米粒子是球形的,粒度具有很大的变化;另一方面,通过乳液蒸发产生的纳米颗粒是球形的,并且是无定形的并且呈现均匀的纳米颗粒尺寸分布。甲烯鎓从纳米颗粒中释放酸pH(小于4),该条件可以在小肠中更好地提供矿物质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号